insulin

The Health2Sync app integrates with the NovoPen 6 and NovoPen Echo Plus to view dose logs.
By  Adam Ang 03:40 am March 14, 2022
Taiwanese chronic disease management company Health2Sync has entered into a partnership with Danish pharmaceutical firm Novo Nordisk to help patients undergoing insulin therapy wirelessly transfer dose logs to a mobile health app.  The Health2Sync mobile app is now able to sync patients' dose logs, including time and dosage per injection, from the newly released NovoPen 6 and NovoPen Echo Plus...
Sanofi Anthony Jones and Health2Sync Ed Deng
By  Adam Ang 03:39 am December 8, 2021
Health2Sync, a digital health startup based in Taiwan, and French multinational pharmaceutical firm Sanofi have extended their collaboration to soon come up with and market a new insulin management solution.  WHY IT MATTERS The companies noted the "suboptimal" use of insulin in Taiwan and Asia. A recent study published in the Journal of Diabetes Investigation shared that approximately half of...
By  Laura Lovett 01:55 pm June 3, 2020
This morning Bigfoot Biomedical, a diabetes startup focused on automating insulin delivery through a connected insulin pen, picked up an extra $10 million Series C funding, closing the round at $55 million. Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders.  When the first $45 million...
By  Dave Muoio 11:24 am February 5, 2018
The Juvenile Diabetes Research Foundation (JDRF) and Massachusetts-based Cam Med, a company specializing in microfluidic-based drug delivery technologies, announced a partnership today focused on development of a thin, flexible, patch-based insulin pump for artificial pancreas systems. "JDRF is excited to partner with Cam Med on improving insulin delivery hardware,” Jaime Giraldo, program...
By  Jonah Comstock 04:31 pm November 16, 2017
Medical device software company Voluntis has received an updated FDA clearance (as well as an updated CE mark) for its Insulia app, a "digital companion" app for people with Type 2 diabetes. Insulia offers realtime basal insulin dose coaching, and the new clearance makes the app usable with two additional brands of insulin: Basaglar and Tresiba. The app had already worked for users of Lantus,...
By  Jonah Comstock 01:59 pm July 25, 2017
Senseonics and TypeZero's R&D partnership around the artificial pancreas is leveling up. The two organizations announced today that they would team up with pharmaceutical and medical device company Roche to launch three European clinical trials of their combined closed-loop system. The research is backed by the National Institutes of Health (NIH) through its International Diabetes Closed Loop...
By  Jonah Comstock 08:56 am April 9, 2015
In March, Roche received FDA clearance for its Accu-Chek Connect companion app, and, less than a month later, issued a recall of that app. App recalls, which are becoming more common as more and more apps receive FDA clearance, are less severe than device recalls because they can often be ameliorated with a quick software patch. The app, available only on Android at present, helps patients track...
By  Brian Dolan 08:26 am October 21, 2014
For the second time since it announced its HealthKit plans, Apple has made a mistake related to blood glucose measurement units. Last week the company pulled the glucose tracking feature out of its Health app for users in some countries where glucose is tracked in millimoles per liter (mmol/L) and not milligrams per deciliter (mg/dL) like they are in the US. "If you measure your blood glucose...